Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. K. (Kevin) Damman

Research interests

Kevin Damman is clinical cardiologist and head of the heart transplant and left ventricular assist device program at the University Medical Center Groningen. His research focuses on acute and advanced heart failure, with particular emphasis on the cardiorenal axis. Current research interests are focused on improving treatment of acute heart failure patients, including early assessment of effect of decongestive therapies, SGLT2-inhibition in (acute) heart failure and the role of the kidney in the process of cardiorenal interaction. He is principle investigator of the EMPA-RESPONSE-AHF study  on empagliflozin in acute heart failure and is part of the steering committee of the ADVOR trial investigating acetazolamide in acute heart failure. Dr Damman is associate editor of the European Journal of Heart Failure and serves as official European Society of Cardiology (ESC) Journals Twitter editor. Furthermore, he is member of the working groups on Cardiorenal Dysfunction and Acute Heart Failure from the Heart Failure Association of the ESC.

Publicaties

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology

Discharge Medication After Natriuresis-Guided Dosing of Diuretic Therapy in Patients Hospitalized for Acute Heart Failure: A PUSH-AHF Substudy

Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study

When Kidney Function Declines But Therapy Still Works: The Case for Nonsteroidal MRA Therapy in Heart Failure

Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF

Calciprotein particle counts associate with vascular remodelling in chronic kidney disease

Cardiorenal interactions in heart failure - insights from recent therapeutic advances

Clinical and proteomic profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction

Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

Pers/media

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Tegelijkertijd nieuw hart én nieuwe lever voor patiënte in Groningen

Hoe blijft chirurg 12 uur scherp? 'Ik drink alleen water'

Acetazolamide in de behandeling van acuut hartfalen

SGLT2-remmers bij HFrEF: praktische adviezen bij eGFR-daling

Nierfunctie, elektrolyten en hartfalen

Nonsteroidal MRA Drug Cuts Risks in Earlier Diabetic Kidney Disease